Skip to main content
Clinical Trials/NCT04208503
NCT04208503
Unknown
Not Applicable

Ultrasound and Functional Thyroid Evaluation in Preterm Infants Born Between 24 and 32 Weeks of Gestation

Princess Anna Mazowiecka Hospital, Warsaw, Poland1 site in 1 country200 target enrollmentDecember 19, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thyroid
Sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Enrollment
200
Locations
1
Primary Endpoint
Determination of FT4 and TSH values in preterm infants born at 29-32 weeks of gestation
Last Updated
4 years ago

Overview

Brief Summary

Thyroid disorders are most commonly concomitant with prematurity and still remains a controversial topic. The incidence of a temporary form of hypothyroidism among preterm neonates is higher than in the general population. Transient prematurity hypothyroxinemia is defined as a temporary reduction in FT4 values without increase in TSH values. Currently, there is no consensus about normal thyrotropine (TSH) and free thyroxine (FT4) values in preterm infants.

The aim of this study is to determine the volume of the thyroid gland in preterm infants born between 24 and 32 weeks of gestation inborn or admitted to the unit within 14 days from birth and compare it with the results of TSH and FT4 blood concentration. Besides, the objective of the study is to determine values of thyroid hormones in premature infants born before 33 wk gestation to help neonatologist to interpreter the thyroid hormone results

Detailed Description

Thyroid disorders are most commonly concomitant with prematurity and still remains a controversial topic. Preterm infants are susceptible to thyroid disorders due to many reasons including immaturity of hypothalamopituitary-thyroid axis, non-thyroidal illness, impaired synthesis and metabolism of thyroid hormones, medication administration like dopamine, steroids, caffeine.The incidence of a temporary form of hypothyroidism among preterm neonates is higher than in the general population. Transient prematurity hypothyroxinemia is defined as a temporary reduction in FT4 values without increase in TSH values. It is a diagnostic challenge in order to differentiate it from thyroid disfunction in the critically ill patient. Currently, there is no consensus about normal thyrotropine (TSH) and free thyroxine (FT4) values in preterm infants. Given the delayed appearance of TSH value increase in preterm newborns additional thyroid evaluation methods are sought. We believe the thyroid ultrasound might prove helpful. The aim of this study is to determine the volume of the thyroid gland in preterm infants born between 24 and 32 weeks of gestation inborn or admitted to the unit within 14 days from birth and compare it with the results of TSH and FT4 blood concentration. We will performed the thyroid ultrasound to estimate the thyroid volume to aid in the comparative evaluation of infants with suspected thyroid disease. The value of sonography thyroid volume will give specialists possibility to identify a gland as normal, small or enlarged. Besides, the objective of the study is to determine value of thyroid hormones in premature infants born before 33 wk gestation to help neonatologist to interpreter the thyroid hormone results

Registry
clinicaltrials.gov
Start Date
December 19, 2019
End Date
December 31, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • preterm infants born between 24 and 32 weeks of gestation (estimated by ultrasound)
  • in born or admitted to the unit within one week from birth
  • randomization within 7 days from birth
  • parental consent

Exclusion Criteria

  • preterm delivery \<23 weeks of gestation or \> 32 weeks (estimated by ultrasound)
  • major congenital abnormalities
  • no parental consent
  • medications used after birth: steroids, vasopressors (up to 12 hours after end of treatment)
  • positive thyroid stimulating antibodies (TSAb) in the mother
  • mothers with thyroid disease treated with antythyroid drugs
  • mothers treated with amiodarone

Outcomes

Primary Outcomes

Determination of FT4 and TSH values in preterm infants born at 29-32 weeks of gestation

Time Frame: at 14-21 day of life, at 32 and 36 weeks of PCA

FT4 and TSH - blood concentration

Determination of ultrasound thyroid volume in both groups of preterm infants (i.e., those born at 24-28 weeks of gestation and those born at 29-32 weeks of gestation)

Time Frame: at 32 and 36 weeks of PCA

The thyroid volume

Determination of FT4 and TSH values in preterm infants born at 24-28 weeks of gestation

Time Frame: 14-21 days of life, at 32 and 36 weeks of PCA

FT4 and TSH - blood concentration

Evaluation of correlations between circulating thyroid hormone concentrations and thyroid volume

Time Frame: at 32 and 36 weeks of PCA

comparison of values of FT4, TSH and thyroid volume

Secondary Outcomes

  • Analysis of TSH values over time (to determine the optimal time for TSH measurement)(at 14-21 day of life, at 32 and 36 weeks of PCA)
  • Evaluation of changes in ultrasound thyroid volume examined at 32 and 36 weeks of PCA in each group of preterm infants(at 32 and 36 weeks of PCA)
  • Comparison of changes in FT4 evaluated at 32 and 36 weeks of PCA in each group of preterm infants(at 14-21 day of life, at 32 and 36 weeks of PCA)
  • Comparison of changes in TSH evaluated at 32 and 36 weeks of PCA in each group of preterm infants(14-21 days of life, at 32 and 36 weeks of PCA)
  • Evaluation of the correlation between thyroid volume and circulating thyroid hormone concentrations with the head circumference and body mass at 32 and 36 weeks of PCA(at 32 and 36 weeks of PCA)

Study Sites (1)

Loading locations...

Similar Trials